Quantcast

Latest Anticoagulant Stories

2014-09-15 08:29:35

-Direct Oral Anticoagulant Measurement, Automated on ACL TOP® Family of Hemostasis Testing Systems- BEDFORD, Mass., Sept. 15, 2014 /PRNewswire/ --Instrumentation Laboratory (IL) today announced the commercialization in Europe of their HemosIL Direct Thrombin Inhibitor (DTI) Assay. When used in conjunction with HemosIL Dabigatran Calibrators and Controls, this test offers an automated solution for the measurement of dabigatran, a direct oral anticoagulant (DOAC). The assay,...

2014-09-02 23:01:40

The Firm is evaluating Xarelto lawsuits on behalf of patients who suffered uncontrollable internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death, allegedly due to their use of the blood thinner. New York, NY (PRWEB) September 02, 2014 The use of Xarelto (known generically as rivaroxaban) and other new blood thinners is growing at a rapid pace, even as Xarelto lawsuits (http://www.xareltolawsuitcenter.com) continue to mount in courts around the U.S., Bernstein...

2014-09-02 08:30:31

Patients at higher risk of kidney problems due to existing diabetes were also evaluated for the effects of warfarin on kidney function RIDGEFIELD, Conn., Sept. 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new post-hoc sub-analysis of the pivotal phase III RE-LY® trial assessing renal function change in patients with non-valvular atrial fibrillation (NVAF) treated with Pradaxa® (dabigatran etexilate mesylate) compared to warfarin. The...

Aspirin May Reduce The Risk Of Blood Clots Reoccurring
2014-08-27 03:05:36

American Heart Association Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal Circulation. In a combined analysis of two similar independent studies, 1,224 patients who received 100 mg of aspirin a day to treat blood clots were monitored for at least two years. In the International Collaboration of Aspirin Trials for...

2014-08-25 08:27:31

Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug. 25, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from nine company-sponsored Pradaxa® (dabigatran etexilate mesylate) studies will be presented at the European Society of Cardiology (ESC) Congress 2014, August 30 to September 3 in Barcelona, Spain. The abstracts will feature data about the use...

2014-08-21 23:03:25

The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered uncontrollable internal bleeding or other serious injuries allegedly due to their use of the blood thinner. New York, New York (PRWEB) August 21, 2014 Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) filings that allege the blood thinner caused patients to suffer uncontrollable internal bleeding and other serious injuries continue to mount in U.S. courts, Bernstein Liebhard LLP reports. According to court...

2014-08-07 23:11:13

A new study and several lawsuits link Xarelto with uncontrollable bleeding injuries and increased risks of hemorrhage, stroke, pulmonary embolism, and death. Attorneys for Levinson Axelrod are investigating claims that the drug may be too dangerous for patients. Edison, NJ (PRWEB) August 07, 2014 The law firm of Levinson Axelrod is examining new reports that the blood thinner Xarelto, manufactured in Germany by Janssen Pharmaceuticals, Inc., and Bayer AG, may be linked to severe adverse...

2014-07-30 12:30:01

Growth Will Be Driven Primarily By Adoption of Devices to Treat Stroke and Venous Thromboembolism, According to Findings from Decision Resources Group BURLINGTON, Mass., July 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular embolectomy devices, designed for treating stroke patients, as well as...

2014-07-27 23:02:21

Reports of Xarelto Bleeding Mounts As Doctors Are Prescribing Xarelto Over Pradaxa and Seeing a Rise In Adverse Events While Xarelto Lawsuits Begin to be Filed Reports Wright & Schulte LLC Columbus, OH (PRWEB) July 27, 2014 The Institute of Safe Medication Practices (ISMP) Found that the number of serious adverse events such as Xarelto bleeding side-effects reported after the use of the Xarelto blood thinner has now out numbered the complaints filed for its competitor Pradaxa, notes...

2014-07-25 08:27:01

DUBLIN, July 25, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Rodenticides Market by Type, by End User & by Geography - Global Trends & Forecasts to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Rodenticides are used in pest management programs implemented to kill rodents. The rodenticides market includes chemical and natural rodenticides. Rodenticides are widely used in agricultural fields, green houses as well as...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'